Cancer Research Institute

12/12/2025

The Nature’s 10 list "highlights some of the most influential research and important developments shaping our world." Meet 10 people who helped shape science in 2025, including CRI Lloyd J. Old STAR Dr. Yifat Merbl of Weizmann Institute of Science:

Yifat Merbl is part of Nature’s 10, a list of people who shaped science in 2025.

12/11/2025

In 2017, Oswald was diagnosed with stage 4 non-small cell lung cancer. After just two infusions of the immunotherapy checkpoint inhibitor, Keytruda (pembrolizumab), scans showed that the cancer had shrunk dramatically.

Watch Oswald's full story here: https://youtu.be/_FACxuC9czs

12/10/2025

"November 2025 was a landmark month for oncology, characterized by a wave of pivotal regulatory decisions from the FDA that promise to reshape the treatment landscape across numerous cancer types," Targeted Oncology describes. Dive into key regulatory milestones, and explore new approvals from this month: https://bit.ly/4pipTdM

November 2025 marks a transformative month for oncology, featuring groundbreaking FDA approvals that enhance treatment options across various cancer types.

12/09/2025

Alongside a new momentum in data-driven and AI-enabled research, immunology, and computational biology, sits a crisis: shrinking federal funding for biomedical research is demoralizing a generation of young scientists.

“We are on this precipice of potentially losing an entire generation of scientists,” emphasizes CRI's CEO Dr. Alicia Zhou. Many postdocs don’t see a future, not because of lack of talent, but because of lack of opportunity.

"CRI is responding by expanding its fellowship, transition, and mid-career programs, including the new IGNITE Award and STAR Award, to support scientists during their most vulnerable career phases," describes OncoDaily.

“This is not the time to pull back on investment in biology. This is the time to add fuel into the tank.” Hear more from CRI's CEO, in OncoDaily's December issue:

Alicia Zhou: The Mission-Driven Biologist Building the Future of Immunotherapy / Alicia Zhou, Andrei Goga, Bob Weinberg, Cancer research, Cancer Research

12/08/2025

An experimental cancer vaccine developed from researchers at Johns Hopkins Medicine, including CRI Scientific Advisory Council Associate Director Dr. Elizabeth Jaffee and CRI Clinical Innovator Dr. Marina Baretti, has demonstrated early promise in a phase I clinical trial for a rare form of liver cancer that primarily affects children and young adults. Explore:

Novel Liver Cancer Vaccine Achieves Responses in Rare Disease Affecting Children and Young Adults 11/24/2025 Three patients who presented with advanced disease are now believed to be cancer-free Credit: Getty Images Fast Facts Click to Tweet JUST OUT: scientists report early promise f...

12/07/2025

🔬 By participating in an immunotherapy clinical trial, you have the opportunity not only to access a potentially lifesaving treatment, but also to help bring immunotherapies to more patients in the future.

Understand the significance of clinical trials in cancer research, and discover if you're eligible to be matched to one that's right for you, through our Cancer Immunotherapy Clinical Trial Finder:

Cancer clinical trials are critical to bringing new treatments to more patients. See if immunotherapy clinical trials are right for you.

12/06/2025

⏰ When Oswald was diagnosed with stage 4 lung cancer, he was told he might have only weeks to live. Instead, he was declared cancer-free just 6 months after receiving his first immunotherapy treatment.

⭐ Oswald’s journey is a powerful reminder of how far cancer research has come, but also a reminder of how many patients are still waiting. Help accelerate lifesaving cancer research forward, and give more patients more time: https://bit.ly/4oKA5vh

12/05/2025

Are screening guidelines missing the majority of lung cancer cases? In a new study, researchers at Northwestern University Feinberg School of Medicine found that 65% of their lung cancer patients weren't eligible for screening.

“The screening guidelines, as they currently stand, are heavily focused on smoking history and age,” says Dr. Jhanelle Gray at Moffitt Cancer Center. This leaves out “some groups who don’t fit that criteria and are still at risk, and so, when you look at the guidelines, we need to look at expanding the criteria to reach more high-risk patients.”

More in NBC News: https://nbcnews.to/49wUpMb

Researchers at Northwestern Medicine found that 65% of their lung cancer patients weren't eligible for screening. They were likelier to be female, Asian American or nonsmokers.

12/04/2025

"In moments of disruption, leadership matters. The pace of discovery is accelerating, but the systems that sustain it are strained," emphasizes CRI's CEO, Dr. Alicia Zhou. "Patients with cancer cannot wait for stability to return — they need solutions now. Today, our role as convener and catalyst has never been more essential.”

Explore a year of inspiring discoveries and impactful investments with the Cancer Research Institute’s 2025 Annual Impact Report: https://bit.ly/43jXLLE

30+ cancer types, 9 million patients, $570M invested. See how CRI makes an impact in cancer treatment worldwide.

12/03/2025

While he was planning his funeral, Oswald’s doctors were choreographing his cure.

He remembers the moment things started to change. “This amazing doctor walked into my room, and she started to talk about the word that would eventually change my life: immunotherapy." More: https://bit.ly/3LRHEBP

Dancer Oswald Peterson fought back from stage 4 lung cancer with the help of immunotherapy, reclaiming his rhythm and his life. His inspiring journey of hope, resilience, and scientific progress shines bright this Lung Cancer Awareness Month.

12/02/2025

💜 For every patient still holding out for hope, your gift means the world. Thanks to supporters like you, lifesaving cancer research can continue to move forward.

Make an impact today: https://bit.ly/3K0Vt0u

12/02/2025

💜 "Every single day is precious to me. I wouldn’t be here had it not been for cancer research," emphasizes Kristin, who just celebrated 10 years of remission, thanks to immunotherapy.

Your support fuels the scientific discoveries that give patients like Kristin more time and more hope.

On , make a gift to accelerate the next breakthrough: https://bit.ly/3K0Vt0u